Advanced Search

Revoke Authorisation Upon Renunciation, Commerciodel Medicinal Product For Human Use "tacrolimus Accord Healthcare."

Original Language Title: Revoca, su rinuncia, dell'autorizzazione all'immissione in commerciodel medicinale per uso umano «Tacrolimus Accord Healthcare».

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
With no aRM-44/2015-3029 of February 18, 2015 's revoked, pursuant to art. 38, paragraph 9, of the Legislative Decree of April 24, 2006, no. 219, on renunciation of Accord Healthcare Limited the marketing authorisation for the medicinal product in the boxes indicated below.
Medicine: TACROLIMUS ACCORD HEALTHCARE.
Packaging: A.I.C. # 040384152 «5 mg hard capsules» 100 capsules in AL/AL;
A.I.C. # 040384149 «5 mg hard capsules» 60 capsules in AL/AL;
A.I.C. # 040384137 «5 mg hard capsules» 50 capsules in AL/AL;
A.I.C. # 040384125 «5 mg hard capsules» 30 capsules in AL/AL.
If the distribution channel were present stocks of medicine revoked, in the course of validity, the same will be disposed of not later than 180 days after the date of publication of this determination.